Click here for The Motley Fool's resources on Coronavirus and the market.

Karyopharm Therapeutics


Karyopharm Therapeutics  Stock Quote
$19.58 -$1.65 -7.8%
Price as of March 27, 2020, 5:20 p.m. EDT View Interactive KPTI Charts

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

Interactive Chart

News & Analysis: Karyopharm Therapeutics


Market Moves


Biotech's Most Volatile Binary Events for Q1

Risk-taking investors flock to biotech for its constant flow of events that can spike or crush the stock prices of the companies developing the latest therapies.